TrialClinical trials (London, England)2013

Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study.

Abdel G Babiker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.